StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302252% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Finite-Lived Intangible Assets, Gross by Year

Finite-Lived Intangible Assets, Gross ($M) ($M)

BeOne Medicines Finite-Lived Intangible Assets, Gross: $86.5M in FY2025, up 20.3% from a year earlier. That is the highest of the 9 years on record here.

Latest, FY2025
86.5
Period ended Dec 31, 2025
Change on a year earlier
+20.3%
71.9 in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Intangible Assets Note (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFinite-Lived Intangible Assets, Gross ($M) ($M)Year on yearSource
FY2025Dec 31, 202586.5+20.3%Form 10-Q (filed 2026-08-05) ↗
FY2024Dec 31, 202471.9-1.9%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 202373.3+48.1%Form 10-K (filed 2025-02-27) ↗
FY2022Dec 31, 202249.5-4.3%Form 10-K (filed 2024-02-26) ↗
FY2021Dec 31, 202151.7+522.9%Form 10-K (filed 2023-02-27) ↗
FY2020Dec 31, 20208.300.0%Form 10-K (filed 2022-02-28) ↗
FY2019Dec 31, 20198.300.0%Form 10-K (filed 2021-02-25) ↗
FY2018Dec 31, 20188.30+10.7%Form 10-K (filed 2020-03-02) ↗
FY2017Dec 31, 20177.50–Form 10-K (filed 2019-02-28) ↗

Breakdown

What makes up finite-Lived Intangible Assets, Gross

Cite this data

StockData. (2026). BeOne Medicines Finite-Lived Intangible Assets, Gross ($M), annual FY2017–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/intang-gross-tot

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.